参 考 文 献
1. 张兴儒，李青松，项敏泓.结膜松弛症的诊断与治疗［J］.中华眼科杂志，2010，46（1）：88-91.
2. Xing-Ru Zhang, Qing-Song Li, Min-Hong Xiang, et al. Analysis of tear mucin and goblet cells in patients with conjunctivochalasis［J］. Spektrum der Augenheilkd. 2010, 24（4）: 206-213.
3. Xingru Zhang, Qingsong Li, Haidong Zou, et al. Assessing the severity of conjunctivochalasis in a senile population: a community-based epidemiology study in Shanghai, China［J］. BMC Public Health, 2011, 11: 198.
4. Li Qing-song, Zhang Xing-ru, Xiang Min-hong, et al. Clinical evaluations of the quantitative locator for conjunctiva resection used as an instrument for the treatment of conjunctivochalasis［J］. Chin Med J, 2011, 124（13）: 1983-1987.
5. 韩竹梅，张兴儒.结膜松弛症新进展［J］.国际眼科纵览，2011，35（6）：394-399.
6. 张兴儒，许琰，李青松，等.结膜松弛症的临床与基础研究［J］.中国实用眼科杂志，2005，1（23）：83-87.
7. Xingru Zhang, Qingsong Li, Bing Liu, et al. In vivo cross-sectional observation and thickness measurement of bulbar conjunctiva using optical coherence tomography［J］. Invest Ophthalmol Vis Sci, 2011, 52: 7787-7791.
8. 韩竹梅，张兴儒，周欢明，等.两种结膜松弛症诊断与分级标准对老年人群患病率的调查［J］.中华眼视光学与视觉科学杂志，2012，14（8）：494-498.
9. Xing-Ru Zhang, Zhen-Yong Zhang, Matthew R. Hoffman. Electrocoagulative surgical procedure for treatment of conjunctivochalasis［J］. International Surgery, 2012, 97: 90-93.
10. Xing-Ru Zhang, Zhen-Yong Zhang, Matthew R. Hoffman, et al. The effect of age and conjunctivochalasis on conjunctival thickness［J］. Curr Eye Res, 2013, 38（3）: 331-334.
11. de Almeida SF, de Sousa LB, Vieira LA, et al. Clinic-cytologic study of conjunctivochalasis and its relation to thyroid autoimmune diseases prospective cohort study［J］. Cornea, 2006, 25（7）: 789-793.
12. 李轶捷，李青松，张兴儒，等.结膜松弛症研究新进展［J］.国际眼科杂志，2009，9（5）：938-940.
13. 张兴儒，李青松，项敏泓，等.结膜松弛症泪液粘蛋白及球结膜杯状细胞研究［J］.国际眼科杂志，2009， 9（5）：895-899.
14. Ward SK, Wakamatsu TH, Dogru M, et al. The role of oxidative stress and inflammation in conjunctivochalasis［J］. Invest Ophthalmol Vis Sci, 2010, 51（4）: 1994-2002.
15. Li DQ, Meller D, Liu Y, et al, Overexpression of MMP-1 and MMP-3 by cultured conjunctivochalasis fibroblasts［J］. Invest Ophthalmol Vis Sci, 2000, 41（2）: 404-410.
16. 李青松，赵黎，张兴儒，等.利用OCT观察流行性出血性结膜炎的临床研究［J］.国际眼科杂志，2014，14（6）：1092-1094.
17. 符之瑄，张兴儒.睑缘张力改变及其相关疾病的研究进展［J］.国际眼科纵览，2014，38（2）：87-92.
18. 赵黎，李青松，柯梅青，等.眼前节相干光断层扫描在青光眼中的研究进展［J］.国际眼科杂志，2014，14（4）：644-647.
19. Xing-Ru Zhang, Zhen-Yong Zhang, Matthew R. Hoffman. Conjunctival Thickness Measured by OCT［J］. Ophthalmology, 2013, 120（6）: 1305.
20. Xingru Zhang, Qingsong Li, Minhong Xiang, et al. Bulbar conjunctival thickness measurements with optical coherence tomography in healthy Chinese subjects［J］. Invest Ophthalmol Vis Sci, 2013, 54（7）: 4705-4709.
21. Zhang Xing-ru, Zou Hai-dong, Li Qing-song, et al. Comparison study of two diagnostic and grading systems for Conjunctivochalasis［J］. Chin Med J, 2013, 126（16）: 3118-3123.
22. Zhi-Xuan Fu, Xing-Ru Zhang, Zhen-Yong Zhang, et al. Lower eyelid tension in young adults determined by a simply designed lid tensiometer［J］. Cornea, 2014, 33: 518-520.
23. Xing-ru Zhang, Min-hong Xiang, Qing-qing Wu, et al. The tear proteomics analysis of conjunctivochalasis［J］. Speaktrum der Augenheilkund. 2008, 22（5）: 288-294.
24. 王晗敏，姚月蓉，项敏泓，等.结膜松弛症手术切除标本中几种激酶的检测［J］.中华眼外伤职业眼病杂志，2015，37（5）：344-348.
25. 韩竹梅，张振永，张兴儒，等.结膜松弛症患者结膜成纤维细胞中穿透素-3和肿瘤坏死因子-α刺激基因6的表达［J］.中华实验眼科杂志，2014，33（5）：436-439.
26. 柯梅青，张兴儒，李青松.结膜松弛症发病与炎性因子的关系［J］.国际眼科纵览，2015，39（2）：130-134.
27. 韩竹梅，张兴儒，柯梅青，等.基质金属蛋白酶及其组织抑制剂在结膜松弛症成纤维细胞中的表达［J］.中国眼耳鼻喉科杂志，2013，13（6）：365-367.
28. 柯梅青，张兴儒，赵黎，等.眼睑皮肤松弛综合征研究进展［J］.国际眼科纵览，2013，37（5）：301-305.
29. 项敏泓，李轶捷，张兴儒，等.杞精明目汤药物血清对结膜松弛症患者球结膜成纤维细胞中基质金属蛋白酶表达的影响［J］.中华实验眼科杂志，2013，31（10）：940-943.
30. 张兴儒，刘晔翔，盛霞，等.结膜松弛症患者球结膜淋巴管扩张的临床观察［J］.中华眼科杂志，2013，49（6）：547-550.
31. 韩竹梅，张兴儒，张隆，等.结膜松弛症球结膜成纤维细胞的培养和鉴定［J］.眼科，2013，22（2）：105-109.
32. 周蓓，王莉，孙庆玲，等.结膜松弛症手术前后眼表泪液动力学的变化［J］.眼科研究，2009，27：323-325.
33. 符之瑄，张兴儒，韩竹梅.相干光断层成像术在球结膜疾病中的应用进展［J］.国际眼科纵览，2012，36（6）：369-374.
34. 张兴儒，俞章，盛霞，等.结膜松弛症一例［J］.中国眼耳鼻喉科杂志，2012，12（5）：306-309.
35. 项敏泓，饶娅敏，李青松，等.精杞明目汤治疗结膜松弛症的泪液功能改变［J］.眼科新进展，2012，32（8）：743-746.
36. 江利红，张兴儒，张靖华，等.结膜松弛症结膜新月形切除术与双极电凝术的临床疗效观察［J］.中华眼科杂志，2012，48（5）：409-412.
37. 李轶捷，张兴儒，项敏泓，等.结膜松弛症球结膜及筋膜组织的超微结构观察［J］.中华实验眼科杂志，2012，30（7）：638-640.
38. 李轶捷，张兴儒，项敏泓，等.结膜松弛症球结膜成纤维细胞培养的研究［J］.国际眼科杂志，2012，12（4）：632-635.
39. 张兴儒，周欢明，李青松，等.结膜松弛症睑板腺功能的临床观察［J］.中华眼视光学与视觉科学杂志，2011，13（5）：378-381.
40. 项敏泓，张兴儒，李青松，等.精杞明目汤治疗肝肾阴虚型结膜松弛症的临床观察［J］.中国中医眼科杂志，2011，21（5）：270-272.
41. 韩竹梅，张兴儒.中医药对干眼治疗的研究进展［J］.国际眼科杂志，2011，11（9）：1570-1573.
42. 张兴儒，李青松，周欢明，等.睑板腺功能异常［J］.中华眼科杂志，2011，47（1）：74.
43. 项敏泓，张兴儒，李青松，等.液体芯片-飞行时间质谱对结膜松弛症患者泪液蛋白质的分析［J］.眼科研究，2010，28（9）864-868.
44. 项敏泓，张兴儒，张迅轶，等.结膜松弛症泪液中细胞因子检测［J］.国际眼科杂志，2010，10（9）：1702-1703.
45. 项敏泓，张兴儒，李青松，等.结膜松弛症泪液蛋白质肽质量指纹谱分析［J］.眼科新进展，2010，30（1）43-46.
46. 项敏泓，张兴儒，李青松，等.Shotgun方法在正常人泪液蛋白质组学分析中的应用［J］.眼科新进展，2011，31（2）105-107.
47. 陆慧红，张兴儒，周欢明，等.结膜松弛症新月形切除术临床疗效观察［J］.中国眼耳鼻喉科杂志，2011，11（2）：103-106.
48. 陆慧红，张兴儒，周欢明，等.结膜松弛症新月形切除术与药物治疗临床疗效比较［J］.国际眼科杂志，2011，11（3）：428-432.
49. 李青松，张兴儒，郑一仁，等.结膜松弛症定量定位切除术的临床疗效观察［J］.国际眼科杂志，2010，10（4）：495-497.
50. 刘晔翔，李青松，张兴儒，等.半月皱襞松弛致泪溢手术疗效观察［J］.国际眼科杂志，2010，10（1）：145-146.
51. 李青松，张兴儒，项敏泓，等.基质金属蛋白酶在结膜松弛症球结膜组织中的表达［J］.中华眼科杂志，2010，10（9）：838-840.
52. 刘晔翔，李轶捷，张兴儒，等.结膜松弛症球结膜组织中热休克蛋白的表达［J］.中华眼科杂志，2010，10（8）：743-745.
53. 李青松，张兴儒，邹海东，等.上海市曹阳新村街道60岁以上人群结膜松弛症流行病学调查［J］.中华眼科杂志，2009，45（9）：793-798.
54. 张兴儒，项敏泓，吴庆庆，等.结膜松弛症患者泪液蛋白质组学研究［J］.中华眼科杂志，2009，45（2）：135-140.
55. 项敏泓，张兴儒，蔡瑞霞，等.结膜松弛症泪液功能改变的观察［J］.中华眼科杂志，2009，45（6）：556-557.
56. 李青松，张兴儒，项敏泓，等.结膜松弛症的治疗研究现状［J］.国际眼科纵览，2009，33（1）：27-30.
57. 严雅静，张兴儒，项敏泓，等.结膜松弛症下睑缘位置及张力观察［J］.国际眼科杂志，2009，9（3）：1001-1005.
58. 周欢明，张兴儒，李青松，等.结膜松弛症松弛结膜部位的临床观察［J］.临床眼科杂志，2009，17（3）：201-205.
59. 张兴儒，李青松，许琰，等.结膜松弛症［J］.中华眼科杂志，2008，44，（10）：951.
60. 许琰，张兴儒，李青松，等.双极电凝治疗结膜松弛症临床观察［J］.眼外伤及职业眼病杂志，2008，30（12）：935-937.
61. 张兴儒，李青松，项敏泓.结膜松弛症诊断治疗技术［J］.国际眼科杂志，2008，8（11）：2305-2307.
62. 张兴儒，项敏泓，李青松，等.结膜松弛症的发病机理研究［J］.国际眼科杂志，2008，8（5）：1001-1005.
63. 李青松，张兴儒，项敏泓，等.离休干部结膜松弛症观察［J］.国际眼科杂志，2008，7（1）：391-393.
64. 项敏泓，张兴儒，蔡瑞霞，等.结膜松弛症泪液中羊齿状结晶的观察［J］.眼科，2008，17（1）：37-39.
65. 张兴儒，项敏泓，李青松，等.结膜松弛症球结膜杯状细胞改变的观察［J］.眼科新进展，2008，28（11）：805-808.
66. 项敏泓，张兴儒，钟一声.泪液蛋白质组学研究进展［J］.中国实用眼科杂志，2008，26（3）：203-206.
67. 李青松，张兴儒，沈江帆，等.不同浓度99mTcO4-兔眼泪道显像及对球结膜损伤的安全性研究［J］.眼科研究，2007，25（8）：573-574.
68. 李青松，杨振燕，张兴儒，等.结膜松弛症泪液排泄系统99mTc-SPECT动态显像的临床研究［J］.同济大学学报，2006，27（4）：56-60.
69. 张兴儒，蔡瑞霞，王宝华，等.结膜松弛症的病理组织学观察［J］.中华眼科杂志，2004，40（1）：37-39.
70. 张兴儒，李青松，许琰，等.结膜松弛症手术治疗远期疗效观察［J］.眼外伤职业眼病杂志，2004，26（10）：683-685.
71. Watanabe A, Yokoi N, Kinoshita S, et al. Clinicopathologic study of conjunctivochalasis［J］. Cornea, 2004, 23（3）: 294-298.
72. Mimura T, Usui T, Yamamoto H, et al. Conjunctivochalasis and contact lenses［J］. Am J Ophthalmol, 2009, 148（1）: 20-25.
73. Watanabe A, Yokoi N, Kinoshita S, et al. Clinicopathologic study of conjunctivochalasis［J］. Cornea, 2004，23（3）: 294-298.
74. Fodor E, Barabino S, Montaldo E, et al. Quantitative evaluation of ocular surface inflammation in patients with different grade of conjunctivochalasis［J］. Curr Eye Res, 2010, 35（8）: 665-669.
75. Guo P, Zhang SZ, He H, et al. TSG-6 controls transcription and activation of matrix metalloproteinase in conjunctivochalasis［J］. Invest Ophthalmol Vis Sci, 2012, 53（3）: 1372-1380.
76. Guo P, Zhang SZ, He H, et al. PTX3 controls activation of matrix metalloproteinase 1 and apoptosis in conjunctivochalasis fibroblasts［J］. Invest Ophthalmol Vis Sci, 2012, 53（7）: 3414-3423.
77. Acera A, Vecino E, Duran JA. Tear MMP-9 levels as a marker of ocular surface inflammation in conjunctivochalasis［J］. Invest Ophthalmol Vis Sci, 2013, 54（13）: 8285-8291.
78. 张兴儒，李青松.结膜松弛症研究进展［J］.中国眼耳鼻喉科杂志，2004，4（6）：396-397.
79. 张兴儒，许琰，刘晔翔.眼轮匝肌缩短术治疗结膜松弛症［J］.眼科新进展，2003，23（增）：10.
80. 张兴儒，俞彰，刘晔翔，等.结膜松弛症超微结构电镜研究［J］.中国眼耳鼻喉科杂志，2003，3（4）：223-224.
81. 张兴儒，许琰，李青松，等.结膜松弛症眼表知觉敏感度观察［J］.眼科，2003，12（1）：28-29.
82. 许琰，张兴儒.四种术式治疗结膜松弛症疗效观察［J］.眼视光学杂志，2003，5（3）：178-180.
83. 许琰，张兴儒.结膜松弛症手术疗效比较［J］.中国实用眼科杂志，2003，21（13）：353-355.
84. 张兴儒.结膜松弛症性溢泪的手术治疗［J］.中国实用眼科杂志，2002，20（4）：299-301.
85. 张兴儒，沈江帆，王雁程，等.放射核素动态显像评估结膜松弛对泪液排泄系统的影响［J］.眼科，2002，11（4）：211-214.
86. 张兴儒，刘晔翔，许琰等.结膜松弛症的泪液学观察［J］.中国眼耳鼻喉科杂志，2002，2（6）：364-374.
87. 张兴儒，李青松，许琰，等.眼结膜松弛的临床分级探讨［J］.眼科，2001，10（6）：361.
88. 张兴儒.结膜松弛与溢泪关系的临床研究［J］.眼科，2001，10（4）：224-226.
89. 张兴儒，梁丽琼，吴在丽，等.结膜松弛症致溢泪临床疗效观察［J］.中华眼科杂志，1999，35（1）：57.
90. Hughes WL. Conjunctivochalasis［J］. Am J Ophthalmol, 1942, 25: 48-51.
91. Bosniak SL, Smith BC. Conjunctivochalasis［J］. Adv Ophthalmic Plast Reconstr Surg, 1984, 3: 153-155.
92. De-Quan Li, Daniel Meller, Yunqi Liu, et al. Overexpreession of MMP-1 and MMP-3 by cultured conjunctivochalasis fibroblas［J］. Investigation Ophthalmology & Visual Science, 2000, 41（2）: 404-410.
93. 刘祖国.关于干眼名词及分级的初级建议［J］.中国眼耳鼻喉科杂志，2004，4（1）：4-5.
94. Mimura T, Yamagami S, Usui T, et al. Changes of conjunctivochalasis with age in a hospital-based study［J］. Am Jophthalmol, 2009, 147: 171-177.
95. 曹永梅，平秀贤，牛玉英，等.通辽市科尔沁区五个社区55岁及以上人群结膜松弛症流行病学调查［J］.中外健康文摘，2009，6：231-232.
96. Daniel Meller, Scheffer C, Tseng G. Conjunctivochalasis: literature review and possible pathophysiology［J］. Survey of Ophthalmology, 1998, 43（3）: 225-232.
97. Francis, D G Chan, P Kim, et al. Case-controlled clinical and histopathological study of conjunctivochalasis［J］. Br J Ophthalmol 2005, 89: 302-305.
98. Murube J. Characteristics and etiology of conjunctivochalasis: historical perspective［J］. Ocul Surf, 2005, 3: 7-14.
99. De Almeida SF, de Sousa LB, Vieira LA, et al. Clinic-cytologic study of conjunctivochalasis and its relation to thyroid automimune diseases: prospective cohort study［J］. Cornea, 2006, 25: 789-793.
100. Wang Y, Dogru M, Matsumoto Y, et al. The impact of nasal conjunctivochalasis on tear functions and ocular surface findings［J］. Am Jophthalmol, 2007, 144: 930-937.
101. Erdogam-PoyrazC, MocanMC, Irkec M, et al. Delayed tear clearance in patients with conjunctivochalasis is associated with punctal occlu-sion［J］. Cornea, 2007, 26: 290-293.
102. 王晓春，杨家干，张前卫，等.结膜松弛症眼表和泪液的改变［J］.中国眼耳鼻喉科杂志，2010，10：87-89. 103. 胡琳君，成霄黎.结膜松弛症的99mTc-SPECT研究［J］.山西医科大学学报，2008，39：757-759.
104. Jordan DR, Pelletier CR. Conjunctivochalasis［J］. Can J Ophthalmol, 1996, 31: 192-193.
105. Koray Gumus, Charlene hong, Crockett, et al. Anterior segment optical coherence tomography: A diagnostic instrument for conjunctivochalasis［J］. American Joural of Ophthalmology, 2010, 150: 798-806.
106. Höh H, Schirra F, Kienecher C, et al. Lid-parallel conjunctival folds are a sure diagnostic sign of dry eye［J］. Ophthalmologe, 1995, 92: 802-808.
107. Danial Meller, Scheffer C, G Tseng. Conjunctivochalasis: Literature review and possible pathophysiology［J］. Survey of Ophthalmology, 1998, 43: 225-232.
108. Eifrig DE. Grading conjunctivochalasis［J］. Suzv Ophthalmol, 1999, 44: 93- 94.
109. Kheirkhah A, Casas V, Esquenazi S, et al. New surgical approach for superior conjunctivochalasis［J］. Cornea, 2007, 26: 685-691.
110. Brodbaker E, Bahar I, Slomovic AR. Novel use of fibrin glue in the treatment of conjunctivochalasis［J］. Cornea, 2008, 27: 950-952.
111. Rodrigues EB, Johanson M, Penha FM. Anterior segment tomography with the cirrus optical coherence tomography［J］. J Ophthalmol, 2012, 2012: 1-5.
112. Feng Y, Simpson TL. Corneal, limbal, and conjunctival epithelial thickness from optical coherence tomography［J］. Optom Vis Sci, 2008, 85: 880-883.
113. Liu X, Wang F, Xiao Y, et al. Measurement of the limbus-insertion distance in adult strabismus patients with anterior segment optical coherence tomography［J］. Invest Ophthalmol Vis Sci, 2011, 52: 8370-8373.
114. 肖颖，叶信海.眼前节OCT技术对人眼水平直肌止端解剖结构的研究［J］.中华实验眼科杂志，2011，29：635-639.
115. Singh M, Chew PT, Friedman DS, et al. Imaging of trabeculectomy blebs using anterior segment optical coherence tomography［J］. Ophthalmology, 2007, 114: 47-53.
116. Leung CK, Yick DW, Kwong YY, et al. Analysis of bleb morphology after trabeculectomy with Visante anterior segment optical coherence tomography［J］. Br J Ophthalmol, 2007, 91: 340-344.
117. Park HYL, Ahn MD. Imaging of trabeculectomy blebs with Visante anterior segment optical coherence tomography after digital ocular compression［J］. Jpn J Ophthalmol, 2011, 56: 38-45.
118. Gouws P, Buys YM, Rachmiel R, et al. Finger massage versus a novel massage device after trabeculectomy［J］. Can J Ophthalmol, 2008, 43: 222-224.
119. Gumus K, Crockett CH, Pflugfelder SC. Anterior segment optical coherence tomography: a diagnostic instrument for conjunctivochalasis［J］. Am J Ophthalmol, 2010, 150: 798-806.
120. Soliman W, Mohamed TA. Spectral domain anterior segment optical coherence tomography assessment of pterygium and pinguecula［J］. Acta Ophthalmologica, 2010, 90: 461-465.
121. Kheirkhah A, Adelpour M, Nikdel M, et al. Evaluation of conjunctival graft thickness after pterygium surgery by anterior segment optical coherence tomography［J］. Curr Eye Res, 2011, 36: 782-786.
122. Shields CL, Belinsky I, Romanelli-Gobbi M, et al. Anterior segment optical coherence tomography of conjunctival nevus［J］. Ophthalmology, 2011, 118: 915-919.
123. Welch J, Srinivasan S, Lyall D, et al. Conjunctival lymphangiectasia: a report of 11 cases and review of literature［J］. Surv Ophthalmol, 2012, 57: 136-148.
124. Watanabe A, Yokoi N, Kinoshita S, et al. Clinicopathologic study of conjunctivochalasis［J］. Cornea, 2004, 23: 294-298.
125. Daya SM, Papdopoulos R. Ocular coherence tomography in lymphangiectasia［J］. Cornea, 2011, 30: 1170-1172.
126. Bianciotto C, Shields CL, Guzman JM, et al. Assessment of anterior segment tumors with ultrasound biomicroscopy versus anterior segment optical coherence tomography in 200 cases［J］. Ophthalmology, 2011, 118: 1297-1302.
127. Sbeity Z, Dorairaj S, McCormick S, et al. Clinicopathologic correlation of a subconjunctival foreign body using ultrasound biomicroscopy and anterior segment ocular coherence tomography［J］. Eye （Lond）, 2009, 23: 489-491.
128. Hessen M, Akpek EK. Dry eye: an inflammatory ocular disease［J］. J Ophthalmic Vis Res, 2014, 9（2）: 240-250.
129. Stevenson W, Chauhan SK, Dana R. Dry eye disease: an immune-mediated ocular surface disorder［J］. Arch Ophthalmol, 2012, 130（1）: 90-100.
130. Coursey TG, de Paiva CS. Managing Sjögren’s Syndrome and non-Sjögren Syndrome dry eye with antiinflammatory therapy［J］. Clin Ophthalmol, 2014, 8: 1447-1458.
131. Kim KW, Ha HS, Kim JC. Ischemic tissue injury and progenitor cell tropism: significant contributors to the pathogenesis of pterygium［J］. Histol Histopathol, 2015, 30（3）: 311-320.
132. Bianchi E, Scarinci F, Grande C, et al. Immunohistochemical profile of VEGF, TGF-β and PGE2 in human pterygium and normal conjunctiva: experimental study and review of the literature［J］. Int J Immunopathol Pharmacol, 2012, 25（3）: 607-615.
133. Pan HW, Zhong JX, Jing CX. Comparison of fibrin glue versus suture for conjunctival autografting in pterygium surgery: a meta-analysis［J］. Ophthalmology, 2011, 118（6）: 1049-1054.
134. Pacharn P, Vichyanond P. Immunomodulators for conjunctivitis［J］. Curr Opin Allergy Clin Immunol, 2013, 13（5）: 550-557.
135. Dartt DA, Masli S. Conjunctival epithelial and goblet cell function in chronic inflammation and ocular allergic inflammation［J］. Curr Opin Allergy Clin Immunol, 2014, 14（5）: 464-470.
136. Galicia-Carreón J, Santacruz C, Hong E, et al. The ocular surface: from physiology to the ocular allergic diseases［J］. Rev Alerg Mex, 2013, 60（4）: 172-183.
137. Vichyanond P, Pacharn P, Pleyer U, et al. Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes［J］. Pediatr Allergy Immunol, 2014, 25（4）: 314-322.
138. Chen JJ, Applebaum DS, Sun GS, et al. Atopic keratoconjunctivitis: A review［J］. J Am Acad Dermatol, 2014, 70（3）: 569-575.
139. Sy H, Bielory L. Atopic keratoconjunctivitis［J］. Allergy Asthma Proc, 2013, 34（1）: 33-41.
140. Suzuki T. Meibomitis-related keratoconjunctivitis: implications and clinical significance of meibomian gland inflammation［J］. Cornea, 2012, 31（1）1: S41-S44.
141. Fuchs E. UberBlepharochalasis［J］. Wien Klim Wochenschr, 1896, 9: 109-110.
142. Dózsa A, Károlyi ZS, Degrell P. Bilateral blepharochalasis［J］. JEADV. 2005, 19: 725-728.
143. 李月芝，杨云东，张歆，等.眼睑松弛症的手术治疗分析［J］.国际眼科，2009，9（6）：1213-1214.
144. Hallahan KM, Sood A, Singh AD. Acute episode of eyelid oedema［J］. Br J Ophthalmol, 2012, 96（6）: 909-913.
145. García-Ortega P, Mascaro F, Corominas M, et al. Blepharochalasis misdiagnosed as allergic recurrent angioedema［J］. Allergy, 2003, 58（11）: 1197-1198.
146. Shah-Desai S, Sandy C, Collin R. Lax eyelid syndrome or ‘progeria’ of eyelid tissues［J］. Orbit, 2004, 23（1）: 3-12.
147. Nagi KS, Carlson JA, Wladis EJ. Histologic assessment of dermatochalasis: elastolysis and lymphostasis are fundamental and interrelated findings［J］. Ophthalmology, 2011, 118（6）: 1205-1210.
148. deFiguerêdo AA, de Pochat VD, Barreto TF, et al. Management of an unusual presentation of Ascher syndrome［J］. J Craniofac Surg, 2012, 23（6）: 570-571.
149. Schaeppi H, Emberger M, Wieland U, et al. Unilaterale Blepharochalasismitlasionalen IgA-deposis［J］. Hautartzt, 2002, 53: 613-617.
150. Kaneoya K, Momota Y, Hatamochi A, et al. Elastin gene expression in blepharochalasis［J］. J Dermatol, 2005, 32（1）: 26-29.
151. Karaconji T, Skippen B, Di Girolamo N. et al. Doxycycline for treatment of blepharochalasis via inhibition of matrix metalloproteinases［J］. Ophthal Plast Reconstr Surg, 2012, 28（3）: 76-78.
152. A Sugamata. Infraeyebrow blepharoplasty for blepharochalasis of the upper eyelid: its indication and priority［J］. Plast Surg Int, 2012, 2012: 975097.
153. 李冬梅，陈涛，侯志嘉，等.眼睑松弛症的临床特征及并发畸形的手术治疗［J］.中华眼科杂志，2012，48（8）：696-700.
154. 孙洁，李冬梅，陈涛，等.眼睑皮肤松弛症及其伴发畸形的手术整复［J］.眼科，2008，17（6）：375-378.
155. 邵燕，赵长涛，姜虎林，等.眼睑松弛症伴泪腺脱垂的手术治疗［J］.眼外伤职业眼病杂志，2010，32（8）：634-635.
156. 李斌，李俊逸，王翠青，等.青年性眼睑皮肤松弛症的手术治疗［J］.中华眼外伤职业眼病杂志，2011，33（1）：65-67.
157. 魏楠，于颖，李文君，等.眼睑松弛症伴泪腺脱垂的手术治疗［J］.中国实用眼科杂志，2012，30（2）：185-186.
158. Collins MJ, Buehren T, Trevor T, et al. Factors influencing lid pressure on the cornea［J］. Eye Contact Lens, 2006, 32: 168-173.
159. Shaw AJ, Collins MJ, Davis BA, et al. Eyelid pressure: inferences from corneal topographic changes［J］. Cornea, 2009, 28: 181-188.
160. Ehrmann K. Francis I, Stapleton F. A novel instrument to quantify the tension of upper and lower eyelids［J］. Cont Lens Anterior Eye, 2001, 24: 65-72.
161. Shaw AJ, Davis BA, Collins MJ, et al. A technique to measure eyelid pressure using piezoresistive sensors［J］. IEEE Trans Biomed Eng, 2009, 56: 2512-2517.
162. Shaw AJ, Collins MJ, Davis BA, et al. Eyelid pressure and contact with the ocular surface［J］. Invest Ophthalmol Vis Sci, 2010, 51: 1911-1917.
163. Hallett M, Evinger C, Jankovic J, et al. Update on blepharospasm: report from the BEBRF International Workshop［J］. Neurology, 2008, 71: 1275-1282.
164. Coscarelli JM. Essential blepharospasm［J］. Semin Ophthalmol, 2010, 25: 104-108.
165. Horovitz SG, Ford A, Najee-Ullah MA, et al. Anatomical correlates of blepharospasm［J］. Transl Neurodegener, 2012, 1: 12-18.
166. Clarimon J, Brancati F, Peckham E, et al. Assessing the role of DRD5 and DYT1 in two different casecontrol series with primary blepharospasm［J］. Mov Disord, 2007, 22: 162-166.
167. Carbon M, Kingsley PB, Su S, et al. Microstructural white matter changes in carriers of the DYT1 gene mutation［J］. Ann Neurol, 2004, 56: 283-286.
168. van Bijsterveld OP, Kruize AA, Bleys RL. Central nervous system mechanisms in Sjogren’s syndrome［J］. Br J Ophthalmol, 2003, 87: 128-130.
169. Pagan FL, Harrison A. A guide to dosing in the treatment of cervical dystonia and blepharospasm with Xeomin（R）: a new botulinum neurotoxin A［J］. Parkinsonism Relat Disord. 2012, 18: 441-445.
170. Benecke R, Jost WH, Kanovsky P, et al. A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia［J］. Neurology, 2005, 64: 1949-1951.
171. Roggenkamper P, Jost WH, Bihari K, et al. Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm［J］. J Neural Transm, 2006, 113: 303-312.
172. Wabbels B, Reichel G, Fulford-Smith A, et al. Double-blind, randomised, parallel group pilot study comparing two botulinum toxin type A products for the treatment of blepharospasm［J］. J Neural Transm, 2011, 118: 233-239.
173. Pariseau B, Worley MW, Anderson RL. Myectomy for blepharospasm 2013［J］. Curr Opin Ophthalmol, 2013, 24: 488-493.
174. 刘菊芬，王桂红.针刺治疗眼睑痉挛32例疗效观察［J］.内蒙古中医药，2013，14：39-40.
175. 吴昊权.针刺配合按摩治疗顽固性眼睑痉挛30例临床观察［J］.中医药导报，2011，9：57-58.
176. Murube J. Characteristics and etiology of conjunctivochalasis: historical perspective［J］. Ocul Surf, 2005, 3: 7-14.
177. Watanabe A, Yokoi N, Kinoshita S, et al. Clinicopathologic study of conjunctivochalasis［J］. Cornea, 2004, 23: 294-298.
178. Koursh DM, Modjtahedi SP, Selva D, et al. The blepharochalasis syndrome［J］. Surv Ophthalmol, 2009, 54: 235-244.
179. DeAngelis DD, Carter SR, Seiff SR. Dermatochalasis［J］. Int Ophthalmol Clin, 2002, 42: 89-101.
180. Miyamoto C, Espirito Santo LC, Roisman L, et al. Floppy eyelid syndrome: review［J］. Arq Bras Oftalmol, 2011, 74: 64-66.
181. McNab AA. The eye and sleep［J］. Clin Experiment Ophthalmol, 2005, 33: 117-125.
182. Shah-Desai S, Sandy C, Collin R. Lax eyelid syndrome or ‘progeria’ of eyelid tissues［J］. Orbit, 2004, 23: 3-12.
183. 张雷，闻华明，赵芳，等.复方樟柳碱颞浅动脉旁皮下注射联合针灸治疗眼睑痉挛的疗效［J］.国际眼科杂志，2013，13（5）：1032-1033.
184. Miyazaki Y, Sako W, Asanuma K, et al. Efficacy of zolpidem for dystonia: a study among different subtypes［J］. Frontiers in Neurology, 2012, 3: 58.
185. Ochudlo S, Bryniarski P, Opala G. Botulinum toxin improves the quality of life and reduces the intensification of depressive symptoms in patients with blepharospasm［J］. Parkinsonism & Related Disorders, 2007, 13（8）: 505-508.
186. 尹鹭峰，胡学强，林熹.A型肉毒毒素治疗Meige综合征［J］.中国现代神经疾病杂志，2006，6（5）：415-416.
187. Truong D. Botulinum toxins in the treatment of primary focal dystonias［J］. Journal of the Neurological Sciences, 2012, 316（1）: 9-14.
188. 宋剑涛，杨薇.高健生治疗眼睑痉挛用药经验举隅［J］.中国中医眼科杂志，2009，19（6）：331-332.
189. 张年顺.唐宋金元名医全书大成-李东垣医学全书［M］.北京：中国中医药版社，2006，251.
190. 周伟光.灵龟八法开穴针刺治疗眼睑痉挛的疗效观察［J］.广西中医药，2009，32（6）：38-39.
191. 林海平，王伟志，王舒.齐刺加浮刺法治疗眼肌痉挛20例［J］.上海针灸杂志，2013，32（4）：312.
192. 刘坚，徐红，张仁.益气通络针刺法治疗眼睑痉挛疗效观察［J］.中国针灸，2014，34（1）：37-40.
193. 李晓华，李锦，王勤，等.归脾汤加减合针刺治疗眼睑痉挛40例［J］.中国中医药科技，2013，20（5）：538-539.
194. 邓吕红，李伟力.角膜胶原蛋白研究进展［J］.国际眼科杂志，2008，8（3）：557-560.
195. Lynn AK, Yannas IV, Bonfield W. Antigenicity and immunogenicity of collagen. J Biomed Mater Res B Appl Biomater, 2004, 71（2）: 343-354.
196. 赵长霖，彭琦，谢汉平，等. ECM, MMP与角膜结构和角膜损伤修复［J］.国际眼科杂志，2006，6（1）：173-177.
197. Romero-Jiménez M, Santodomingo-Rubido J, Wolffsohn JS. Keratoconus: a review［J］. Cont Lens Anterior Eye, 2010, 33（4）: 157-166.
198. Meek KM, Tuft SJ, Huang Y, et al. Changes in collagen orientation and distribution in keratoconus corneas［J］. Invest Ophthalmol Vis Sci, 2005， 46（6）: 1948-1956.
199. McKay TB, Lyon D, Sarker-Nag A, et al. Quercetin attenuates lactate production and extracellular matrix secretion in keratoconus［J］. Sci Rep, 2015, 5: 9003.
200. Shetty R, Sathyanarayanamoorthy A, Ramachandra RA, et al. Attenuation of lysyloxidase and collagen gene expression in keratoconus patient corneal epithelium corresponds to disease severity［J］. Mol Vis, 2015, 21: 12-25.
201. Wollensak G, Spoerl E, Seiler T. Increased resistance of crosslinked cornea against enzymatic digestion［J］. Curr Eye Res, 2004, 29（1）: 35-40.
202. Hafezi F, Mrochen M, Iseli HP, et al. Collagen crosslinking with ultraviolet-A and hypoosmolar riboflavin solution in thin corneas［J］. J Cataract Refract Surg, 2009, 35（4）: 621-624.
203. Gu SF, Fan ZS, Wang LH, et al. A short-term study of corneal collagen cross-linking with hypo-osmolar riboflavin solution in keratoconic corneas［J］. Int J Opthalmol, 2015, 8（1）: 94-97.
204. Ucakhan OO, Saglik A. Outcome of two corneal collagen crosslinking methods in bullous keratopathy due to Fuchs’endothelial dystrophy［J］. Case Rep Med, 2014, 2014: 463905.
205. Alhayek A, Lu PR. Corneal collagen crosslinking in keratoconus and other eye disease［J］. Int J Opthalmol, 2015, 8（2）: 407-418.
206. Wollensak G, Spörl E, Reber F, et al. Corneal endothelial cytotoxicity of riboflavin/UVA treatment in vitro［J］. Ophthalmic Res, 2003, 35（6）: 324-328.
207. Wollensak G, Spoerl E, Reber F, et al. Keratocyte cytotoxicity of riboflavin/UVA-treatment in vitro［J］. Eye（Lond）, 2004, 18（7）: 718-722.
208. McBrien NA, Jobling AI, Gentle A. Biomechanics of the sclera in myopia: extracellular and cellular factors［J］. Optum Vis Sci, 2009, 86（1）: E23-30.
209. Frost MR, Norton TT. Alterations in protein expression in tree shrew sclera during development of lensinduced myopia and recovery［J］. Invest Ophthalmol Vis Sci, 2012, 53（1）: 322-336.
210. Tian XD, Cheng YX, Liu GB, et al. Expressions of type I collagen, α2 integrin and β1 integrin in sclera of guinea pig with defocus myopia and inhibitory effects of bFGF on the formation of myopia［J］. Int J Ophthalmol, 2013, 6（1）: 54-58.
211. Wollensak G, Iomdina E. Long-term biomechanical properties of rabbit sclera after collagen crosslinking using riboflavin and ultraviolet A （UVA）［J］. Acta Ophthalmol, 2009, 87（2）: 193-198.
212. Zhao X, Wang MM, Zhang FJ. Advanced research in the safety of UVA-riboflavin cross-linking for strengthening corneal and scleral tissue［J］. Zhonghua Yan Ke Za Zhi, 2013, 49（2）: 189-192.
213. Danysh BP, Duncan MK. The lens capsule［J］. Exp Eye Res, 2009, 88（2）: 151-164.
214. Cammas L, Wolfe J, Choi SY, et al. Integrin-linked kinase deletion in the developing lens Leads to capsule rupture, impaired fiber migration and non-apoptotic epithelial cell death［J］. Invest Ophthalmol Vis Sci, 2012, 53（6）: 3067-3081.
215. Bishop PN. Structural macromolecules and supramolecular organisation of the vitreous gel［J］. Prog Retin Eye Res, 2000, 19（3）: 323-344.
216. Richards AJ, Morgan J, Bearcroft PW, et al. Vitreoretinopathy with phalangeal epiphyseal dysplasia, a typeⅡ collagenopathy resulting from a novel mutation in the C-propeptide region of the molecule［J］. J Med Genet, 2002, 39（9）: 661-665.
217. Itakura H, Kishi S, Kotajima N, et al. Vitreous collagen metabolism before and after vitrectomy［J］. Graefe’s Arch Clin Exp Ophthalmol, 2005, 243（10）: 994-998.
218. Clark IM, Swingler TE, Sampieri CL, et al. Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases［J］. Int J Biochem Cell Biol, 2008, 40（6-7）: 1362-1378.
219. Acera A, Rocha G, Vecino E, et al. Inflammatory Markers in the Tears of Patients with Ocular Surface Disease［J］. Ophthalmic Res, 2008, 40（6）: 3115-3121.
220. Huang Y, Sheha H, Tseng SC. Conjunctivochalasis Interferes with Tear Flow from Fornix to Tear Meniscus［J］. Ophthalmology, 2013, 120（8）: 1681-1687.
221. Gumus K, Crockett CH, Pflugfelder SC. Anterior segment optical coherence tomography a diagnostic instrument for conjunctivochalasis［J］. Am J Ophthalmol, 2010, 150（6）: 798-806.
222. Erdogan-Poyraz C, Mocan MC, Irkec M, et al. Delayed tear clearance in patients with conjunctivochalasis is associated with punctal occlusion［J］. Cornea, 2007, 26（3）: 290-293.
223. Erdogan-Poyraz C, Mocan MC, Bozkurt B, et al. Elevated tear interleukin-6 and interleukin-8 levels in patients with conjunctivochalasis［J］. Cornea, 2009, 28（2）: 189-193.
224. Acera A, Suárez T, Rodríguez-Agirretxe I, et al. Changes in tear protein profile in patients with conjunctivochalasis［J］. Cornea, 2011, 30（1）: 42-49.
225. Fodor E, Kosina-Hagyó K, Bausz M, et al. Increased Tear Osmolarity in Patients with Severe Cases of Conjunctivochalasis［J］. Curr Eye Res, 2012, 37（1）: 80-84.
226. Yokoi N, Komuro A, Nishii M, et al. Clinical impact of conjunctivochalasis on the ocular surface［J］. Cornea, 2005, 24（8）: S24-S31.
227. Francis IC, Chan DG, Kim P, Wilcsek G, et al. Case-controlled clinical and histopathologicalstudy of conjunctivochalasis［J］. Br J Ophthalmol, 2005, 89（3）: 302-305.
228. Gumus K, Pflugfelder SC. Increasing prevalence and severity of conjunctivochalasis with aging detected by anterior segment optical coherence tomography［J］. Am J Ophthalmol, 2013, 155（2）: 238-242.
229. Wang Y, Dogru M, Matsumoto Y, et al. The impact of nasal conjunctivochalasis on tear functions and ocular surface findings［J］. Am J Ophthalmol, 2007, 144（6）: 930-937.
230. Mimura T1，Yamagami S, Usui T, et al. Changes of conjunctivochalasis with age in a hospital-based study［J］. Am J Ophthalmol, 2009, 147（1）: 171-177.
231. Mimura T, Usui T, Yamagami S, et al. Relationship between conjunctivochalasis and refractive error［J］. Eye Contact Lens, 2011, 37（2）: 71-78.
232. Mimura T, Yamagami S, Kamei Y, et al. Influence of Axial Length on Conjunctivochalasis［J］. Cornea, 2013, 32（8）: 1126-1130.
233. Mimura T, Usui T, Yamamoto H, et al. Conjunctivochalasis and Contact Lenses［J］. Am J Ophthalmol, 2009, 148（1）: 20-25.
234. Han ZM, Chen DY, Li JS, et al. Flow cytometric cell-cycle analysis of cultured fibroblasts from the giant panda, Ailuropoda melanoleuca L［J］. Cell Biol Int, 2003, 27 （4）: 349-53.
235. 王美芬，张兴儒，吴凯琳，等.新月形松弛结膜切除术的护理配合［J］.上海护理，2012，12（5）：56-57.
236. 张桂丽，张兴儒，张振永，等.眼位训练法在结膜松弛症新月形切除术中的应用［J］.上海护理杂志，2014，14（2）：30-32.
237. 张桂丽，张兴儒，李青松，等.结膜松弛症手术治疗的护理观察［J］.中国现代医生，2010，48（10）：58-59，65.
238. 张桂丽，张兴儒，李青松.结膜松弛症手术治疗的护理体会［J］.上海护理，2008，8增刊（2）：116-118.